MX9710260A - Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. - Google Patents
Isocromanos 1, 6-disustituidos para el tratamiento de migrañas.Info
- Publication number
- MX9710260A MX9710260A MX9710260A MX9710260A MX9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A MX 9710260 A MX9710260 A MX 9710260A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- isochromans
- disubstituted
- migraine headaches
- headaches
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (fr) | 1995-06-30 | 1996-06-07 | Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9710260A true MX9710260A (es) | 1998-03-29 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9710260A MX9710260A (es) | 1995-06-30 | 1996-06-07 | Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (fr) |
| JP (1) | JPH11509532A (fr) |
| AU (1) | AU6252296A (fr) |
| BR (1) | BR9609631A (fr) |
| CA (1) | CA2225282A1 (fr) |
| CZ (1) | CZ418597A3 (fr) |
| FI (1) | FI974640A (fr) |
| MX (1) | MX9710260A (fr) |
| NO (1) | NO976112L (fr) |
| PL (1) | PL324319A1 (fr) |
| SK (1) | SK164297A3 (fr) |
| WO (1) | WO1997002259A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| ES2338668T3 (es) | 2004-05-05 | 2010-05-11 | F. Hoffmann-La Roche Ag | Arilsulfonil benzodioxanos utiles para la modulacion del receptor 5-ht6 y del receptor 5-ht2a o ambos. |
| DK1831159T3 (da) | 2004-12-21 | 2010-03-22 | Hoffmann La Roche | Tetralin og indanderivater samt anvendelser deraf |
| RU2388748C2 (ru) | 2004-12-21 | 2010-05-10 | Ф. Хоффманн-Ля Рош Аг | Производные тетралина и индана и их применения в качестве антагонистов 5-нт |
| WO2006066756A1 (fr) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Derives de chromane utiles dans le traitement des troubles du systeme nerveux central |
| AU2005318596B2 (en) | 2004-12-21 | 2010-12-23 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-HT receptor ligands |
| KR100899061B1 (ko) | 2004-12-21 | 2009-05-25 | 에프. 호프만-라 로슈 아게 | 테트랄린 및 인단 유도체 및 이의 용도 |
| CN101300246A (zh) | 2005-11-03 | 2008-11-05 | 弗·哈夫曼-拉罗切有限公司 | 作为5－ht6抑制剂的芳基磺酰基色满类化合物作为蛋白激酶抑制剂的吲哚基马来酰亚胺衍生物 |
| BRPI0713736A2 (pt) | 2006-06-20 | 2014-11-18 | Hoffmann La Roche | Derivados de tetralina e indano e emprego destes |
| BRPI0713742A2 (pt) | 2006-06-20 | 2013-02-13 | Hoffmann La Roche | derivados de arilsulfonila naftaleno e usos destes |
| KR101064001B1 (ko) | 2006-06-20 | 2011-09-08 | 에프. 호프만-라 로슈 아게 | 아릴설폰아미딜 테트랄린 유도체 및 이의 용도 |
| EP2404897A4 (fr) * | 2009-03-05 | 2014-02-26 | Sumitomo Chemical Co | Procédé de production de benzène diméthanol à substitution halogène |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| DK0737189T3 (da) * | 1993-12-28 | 2000-03-06 | Upjohn Co | Heterocycliske forbindelser til behandling af CNS-forstyrrelser og cardiovaskulære forstyrrelser |
-
1996
- 1996-06-07 PL PL96324319A patent/PL324319A1/xx unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/fr not_active Abandoned
- 1996-06-07 BR BR9609631A patent/BR9609631A/pt not_active Application Discontinuation
- 1996-06-07 JP JP9505135A patent/JPH11509532A/ja active Pending
- 1996-06-07 MX MX9710260A patent/MX9710260A/es unknown
- 1996-06-07 SK SK1642-97A patent/SK164297A3/sk unknown
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/cs unknown
- 1996-06-07 EP EP96921264A patent/EP0836599A1/fr not_active Withdrawn
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/fr not_active Application Discontinuation
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/no unknown
- 1997-12-30 FI FI974640A patent/FI974640A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK164297A3 (en) | 1998-09-09 |
| FI974640A0 (fi) | 1997-12-30 |
| BR9609631A (pt) | 1999-03-02 |
| JPH11509532A (ja) | 1999-08-24 |
| NO976112D0 (no) | 1997-12-29 |
| PL324319A1 (en) | 1998-05-25 |
| FI974640A (fi) | 1997-12-30 |
| NO976112L (no) | 1998-03-02 |
| EP0836599A1 (fr) | 1998-04-22 |
| CA2225282A1 (fr) | 1997-01-23 |
| CZ418597A3 (cs) | 1998-06-17 |
| WO1997002259A1 (fr) | 1997-01-23 |
| AU6252296A (en) | 1997-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9710260A (es) | Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. | |
| MX9706969A (es) | 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos. | |
| AU7261196A (en) | N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists | |
| FR2706767B1 (fr) | ||
| MY131298A (en) | 5-heteroyl indole derivatives | |
| HK1011972A1 (en) | 3-(3,4-Dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases | |
| HUT70499A (en) | Fluoroalkoxybenzaldehyde derivatives and process for producing them | |
| MY129596A (en) | Quinoline derivatives as tachykinin nk3 receptor antagonists | |
| BG102872A (en) | 6-phenylpyridyl-3-amine derivatives | |
| MY122278A (en) | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position | |
| MXPA04004939A (es) | 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion. | |
| IL110943A0 (en) | Compositions for the treatment of skin disorders | |
| MY115431A (en) | Heterocyclic compounds for the treatment of cns and cardiovascular disorders | |
| BG102818A (en) | D-manitol and method for its preparation | |
| EP0835869A3 (fr) | Agonistes du Récepteur sérotonine 5-HT1F | |
| ZA983704B (en) | Phosphodiesterase 4-inhibiting diazepinoindolones. | |
| ZA961364B (en) | 1-Aryl-2-acylamino-ethane compounds | |
| IL114754A0 (en) | Benzimidazole derivatives | |
| HK1056725A1 (en) | 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry. | |
| MX9801190A (es) | Inhibidores de prolil endopeptidasa. | |
| BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
| YU30403A (sh) | 2-, 3-, 4- ili 5-supstituisani-n1-(benzensulfonil)indoli i njihova upotreba u terapiji | |
| IL128028A0 (en) | Treatment of psychotic disorders | |
| YU22802A (sh) | Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina | |
| IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds |